Cart
sales@molnova.com
Lansoprazole sulfone
CAS No. 131926-99-3
Lansoprazole sulfone( —— )
Catalog No. M22591 CAS No. 131926-99-3
Lansoprazole sulfone is a metabolite of the gastric pump inhibitor Lansoprazole.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 439 | In Stock |
|
| 50MG | 644 | In Stock |
|
| 100MG | 888 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLansoprazole sulfone
-
NoteResearch use only, not for human use.
-
Brief DescriptionLansoprazole sulfone is a metabolite of the gastric pump inhibitor Lansoprazole.
-
DescriptionLansoprazole sulfone is a metabolite of the gastric pump inhibitor Lansoprazole.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number131926-99-3
-
Formula Weight385.36
-
Molecular FormulaC16H14F3N3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (648.74 mM)
-
SMILESCc1c(OCC(F)(F)F)ccnc1CS(=O)(=O)c1nc2ccccc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang D , Yang M , Liu M , et al. Pharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjects[J]. Xenobiotica, 2012.
molnova catalog
related products
-
N-Formyl-Met-Leu-Phe
N-Formyl-Met-Leu-Phe (fMLF) is a synthetic peptide that acts as an agonist at formyl peptide receptors (FPR; Ki = 0.8 pM).
-
DL-Propargylglycine ...
DL-Propargylglycine HCl (DL-Propargyl Glycine HCl) is a potent irreversible inhibitor of cystathionine γ-cleaving enzyme and can be used in the study of heart failure.
-
Cyclic MKEY
MKEY, a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, has been shown to protect against atherosclerosis and aortic aneurysm formation by mediating inflammation, but whether it modulates neuroinflammation and brain injury has not been studied.
